Indeed, EIF4A3 emerged as an actionable splicing factor as its expression is consistently elevated in HCC and associated with increased aggressiveness and shorter survival by modulating the expression and splicing events of key oncogenes such as FGFR4. This evidence concerns the gene FGFR4 and hepatocellular carcinoma.